Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Patient Grand Rounds Example

In this insightful grand rounds example, Carevive focuses on a 76-year-old female patient diagnosed with stage four non-small cell lung cancer, with evidence of brain metastases. The patient’s biomarker status indicates PDL-1 positivity, and she also has a history of diabetes. While the patient continues to work part-time and leads an active lifestyle, she faces…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Carevive on MarketScale.

Share

In this insightful grand rounds example, Carevive focuses on a 76-year-old female patient diagnosed with stage four non-small cell lung cancer, with evidence of brain metastases. The patient’s biomarker status indicates PDL-1 positivity, and she also has a history of diabetes. While the patient continues to work part-time and leads an active lifestyle, she faces the challenges of living alone.

The treatment history reveals a course of immunotherapy, including nivolumab and ipilimumab, followed by pembrolizumab with carboplatin and paclitaxel. Carevive then provides an in-depth analysis of the patient’s symptom burden and treatment bother over the treatment timeline.

Symptom reporting spikes correlate with the treatment course, with certain symptoms standing out as severe, such as decreased appetite, fatigue, and muscle pain. The granular data on symptom interference with daily life highlights fatigue and muscle pain as persistent challenges throughout treatment.

Carevive’s detailed insights go beyond symptom burden, shedding light on the patient’s functional status over time. The patient’s ability to tolerate the multimodal therapy is evident from the maintained moderate function and treatment bother levels.

Through this case study, Carevive demonstrates the power of personalized data-driven insights. Understanding individual patient experiences empowers care teams to tailor support, leading to better treatment decisions, symptom management, and ultimately improved patient outcomes.

Carevive’s commitment to patient-centered care continues to revolutionize oncology treatment, providing clinicians with valuable tools to optimize patient care and well-being. With data-driven insights and a focus on patient quality of life, Carevive sets a new standard in patient care and support.

Carevive

Part of this channel

Carevive

Remote oncology monitoring that connects clinicians and cancer patients between visits.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512